新产业：公司新产品获得医疗器械注册证

Core Viewpoint - The company has received a medical device registration certificate from the Guangdong Provincial Drug Administration for its Angiotensin I assay kit, which is used for the quantitative measurement of Angiotensin I levels in human plasma, aiding in the evaluation of cardiovascular function [1] Group 1: Product Development - The assay kit enhances the company's portfolio in the "hypertension" category within its chemiluminescence testing products [1] - The new product registration is expected to have a positive impact on the company's development [1] Group 2: Financial Impact - The recent product registration will not significantly affect the company's short-term production operations and performance [1]